Evaluating a scar gel for preventing hypertrophic scars

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the safety and efficacy of a scar gel over a 90-day period, comparing its effects to a benchmark product. Participants will apply the gel to recent scars and undergo assessments to measure improvements in scar appearance, hydration, pigmentation, and any associated discomfort. The study aims to determine how well the gel prevents hypertrophic scars in individuals with specific skin types and recent scarring events.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Participants of both sexes aged between 18 and 70 years;
2. Participants with recent scars (\<30 days);
3. Participants with phototypes III to VI according to the Fitzpatrick scale;
4. Agree to follow the trial procedures and attend the center on the days and times determined for evaluations;
5. Understand, agree to and sign the free and informed consent form.
6. Types of scars: cesarean section, breast implant or blunt cut injury.

Exclusion Criteria:

1. Pregnancy or risk of pregnancy;
2. History of atopic or allergic reactions to cosmetic products;
3. Participants who are using topical antibiotics or other skin products on the same area being evaluated;
4. Immunosuppression due to drugs or active diseases;
5. Decompensated endocrine diseases;
6. Relevant clinical history or current evidence of alcohol or other drug abuse;
7. Known history or suspected intolerance to products in the same category;
8. Intense sun exposure up to 15 days before the evaluation;
9. Patients who are using topical antibiotics or other skin products on the same area being evaluated.

Where it's running

• Medcin
  Osasco, Brazil Recruiting
• Medcin Instituto da Pele Ltda
  Osasco, São Paulo, Brazil Not yet recruiting

Study contacts

• Study coordinator: Flávia A. S. Addor
• Email: contato@medcinpesquisa.com.br
• Phone: (55) 11 3683-5366

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Brief topical cryotherapy before steroid injections for keloid and hypertrophic scars

  This study will test whether applying a short burst of topical cryotherapy just before steroid injections lowers pain and makes injections easier for adults getting intralesional triamcinolone for keloid or hypertrophic scars.

  Recruiting Phase 3 University of Pittsburgh · Pittsburgh, Pennsylvania · NCT07336368

• RIG-101 for healthy adults and people with asthma

  This trial will test whether RIG-101 is safe, well tolerated, and can protect healthy adults and adults with asthma from a controlled viral exposure.

  Recruiting at 2 sites Phase 1/2 RIGImmune Inc. · London and 1 other locations · NCT07488897

• Total Coumarin botanical cream for psoriasis vulgaris

  This trial will try a botanical Total Coumarin cream applied twice daily for 8 weeks to see if it helps adults with mild to moderate psoriasis.

  Recruiting Phase 3 Psoriasis Research Institute of Guangzhou · New York, New York · NCT07426120

• Topical nifedipine 0.3% plus lidocaine 1.5% for uncomplicated hemorrhoids

  This will try topical nifedipine 0.3% plus lidocaine 1.5% applied rectally and perianally twice daily to reduce symptoms in adults with uncomplicated acute hemorrhoids.

  Recruiting Cardarelli Hospital · Naples · NCT07295886

• Chitosan cream versus silicone gel and olive oil for preventing hypertrophic scars

  We will test whether applying chitosan cream twice daily can prevent hypertrophic scars in adults whose surgical or traumatic wounds have healed by primary intention within 14 days.

  Recruiting Universiti Sains Malaysia · Kota Bharu, Kelantan and 2 other locations · NCT07269093

• MR‑guided short‑course radiation with chemotherapy and surgery for unresectable locally advanced colon cancer

  This trial will test whether MR‑Linac short‑course radiotherapy followed by chemotherapy and surgery can help people with T4 unresectable locally advanced colon cancer achieve complete tumor removal and better outcomes.

  Recruiting Sichuan Cancer Hospital and Research Institute · Chengdu, Sichuan · NCT06244537

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.